Kadimastem plans listing on Nasdaq through merger
The Israeli biotech stem cell company will delist from the TASE.
Source: globes.co.il
Ronen Twito News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ronen Twito. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ronen Twito Today - Breaking & Trending Today
Kadimastem seeks Nasdaq listing, raises $3.2m from ILEX
The investment will finance clinical development of AstroRx for the treatment of ALS and to begin the clinical development of IsletRx, as a cure for insulin-dependent diabetes.
Source: globes.co.il
Kadimastem hopes to turn corner with new top management
Kadimastem hopes to turn corner with new management The Israeli stem cell technology company has named Asaf Shiloni CEO, after three new expert directors joined its board. Israeli stem cell technology company Kadimastem (TASE: KDST) has had a chequered history, with frequent going concern warnings on its financials, a downward drifting share price from its 2016 peak, and the departure last year of founder and CEO Yossi Ben-Yosef. The company now hopes to have turned a corner with the appointment of a new and experienced CEO and new directors. Kadimastem has named Asaf Shiloni, who was Vice Pr...
Source: globes.co.il
Kadimastem Announces Executive Management Changes
Kadimastem Announces Executive Management Changes USA - English Accomplished US Life Science and Biotech Executive Asaf Shiloni Named New CEO Company Appoints Biotech Industry Leaders Ronen Twito, CPA as Co-Chairperson and Doron Birger and Ron Mayron to the Company's Board of Directors News provided by Share this article NESS ZIONA, Israel, Feb. 1, 2021 /PRNewswire/ -- Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announces the appointment of Asaf Shiloni as CEO. This follows a series of executive management appointments in the last month including Mr. Ronen Twito, CP...
Source: prnewswire.com